Telo Genomics Corp to Present at the Small Cap Growth Virtual Investor Conference December 9th

About this update from Telo Genomics Corp.

[{"type":"image","alt":"Virtual Investor Conferences; Telo Genomics Corp.","displaySize":"","headline":null,"caption":"Virtual Investor Conferences; Telo Genomics Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":200,"url":"https://media.zenfs.com/en/globenewswire.com/7e30d4a58a8d048d2ee1986670b581bc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/wFNFO9V7weOyJzKv3Grwwg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTI4MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/7e30d4a58a8d048d2ee1986670b581bc","width":300,"height":200}},"lazy":false},{"type":"text","content":"Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com","length":140,"tagName":"p"},{"type":"text","content":"TORONTO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSXV: TELO, OTCQB: TDSGF), based in Toronto, a leader in diagnostic and prognostic innovation through its proprietary multi-factor telomere analytics platform, today announced that Guido Baechler, Executive Chairman, will present live at the Small Cap Growth Virtual Investor Conference hosted by VirtualInvestorConferences.com, on December 9th.","length":409,"tagName":"p"},{"type":"text","content":"DATE: December 9th TIME: 2:30 PM ETLINK: REGISTER HEREAvailable for 1x1 meetings: December 16. Schedule 1x1 Meetings here","length":124,"tagName":"p"},{"type":"text","content":"This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.","length":260,"tagName":"p"},{"type":"text","content":"It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.","length":137,"tagName":"p"},{"type":"text","content":"Learn more about the event at www.virtualinvestorconferences.com.","length":65,"tagName":"p"},{"type":"text","content":"Recent Company Highlights","length":25,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Initiated a multiple myeloma MRD clinical trial in collaboration with Cleveland Clinic Cancer Institute using Telo’s 3D telomere analysis.","length":138,"tagName":"p"}]},{"val":[{"type":"text","content...

More updates from Telo Genomics Corp.